RANBAXY LAUNCHES AVESSA IN INDIA FOR ASTHMA

Indian pharmaceutical major Ranbaxy Laboratories Limited has launched Avessa (Formoterol + Fluticasone) inhalation capsules in India for the treatment of asthma. Ranbaxy claims that this unique combination has been launched for the first time in the world combining the fastest acting Long Acting Beta 2 Agonist Formoterol and the most potent inhaled corticosteroid Fluticasone. BioSpectrum (http://www.biospectrumasia.com/content/120906IND1593.asp)